{"meta":{"query_hash":"4aed924b31d0","filters":{"venue":"Cytokines Cellular & Molecular Therapy"},"cohort_total":2,"direct_labels_cover":0,"predictions_cover":2,"exported":2,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/4aed924b31d0","api":"https://metacan.xera.ac/api/v1/cohort?venue=Cytokines+Cellular+%26+Molecular+Therapy"},"results":[{"id":"W2039946232","doi":"10.1080/13684730412331302063","title":"Intracellular cytokine analysis of interferon-? in T cells of patients with chronic myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"Cytokines Cellular & Molecular Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"Medical Research Council Canada","keywords":"Cytokine; Myeloid leukemia; Immunology; Interferon; Intracellular; Medicine; Myeloid; Leukemia; Cancer research; Biology; Cell biology","score_opus":0.009742204197778038,"score_gpt":0.21810943416776749,"score_spread":0.20836722996998944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039946232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917275,0.0050570956,0.0015288573,0.00004854482,0.00007861149,0.0010941379,0.000064215856,0.00004548554,0.00035555506],"genre_scores_gemma":[0.9975157,0.00094816304,0.00063115364,0.00008488658,0.000041788648,0.000049341437,0.00039550307,0.00011117532,0.0002223053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966339,0.00014787554,0.001059073,0.0007394758,0.0008213265,0.0005983482],"domain_scores_gemma":[0.99759185,0.00006912869,0.00052526983,0.0013249384,0.00029959437,0.00018922362],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00017684951,0.0005817005,0.0015346031,0.0011403811,0.000034198074,0.000013450057,0.00037359956,0.00025819754,0.0011423725],"category_scores_gemma":[0.000021491125,0.00047953828,0.0005225558,0.0023790533,0.0002799206,0.000107607266,0.00007815851,0.00035512281,0.000025891339],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011452137,0.0014217236,0.059912976,0.0002034093,0.0036768897,0.00031028822,0.00048192573,0.003977788,0.9217448,0.000044731965,0.000022699021,0.0070575178],"study_design_scores_gemma":[0.014300357,0.002299877,0.028258381,0.00023895862,0.0014706427,0.000004597914,0.000031600688,0.008285594,0.9436202,0.000010463006,0.001040373,0.00043894092],"about_ca_topic_score_codex":0.00020886518,"about_ca_topic_score_gemma":0.000038796414,"teacher_disagreement_score":0.031654593,"about_ca_system_score_codex":0.0013396161,"about_ca_system_score_gemma":0.00022730211,"threshold_uncertainty_score":0.9997707},"labels":[],"label_agreement":null},{"id":"W2073019201","doi":"10.1080/13684730210002319","title":"Increased IFN-? synthesis by T cells from patients on imatinib therapy for chronic myeloid leukemia","year":2002,"lang":"en","type":"article","venue":"Cytokines Cellular & Molecular Therapy","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Imatinib; Medicine; Cytokine; Myeloid leukemia; Immunology; Tyrosine-kinase inhibitor; White blood cell; Myeloid; Stem cell; Internal medicine; Cancer; Biology","score_opus":0.014267104526376168,"score_gpt":0.23014121510386867,"score_spread":0.2158741105774925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073019201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98235244,0.0112093575,0.001063267,0.00030993653,0.00032955135,0.0031510135,0.0005112817,0.0002549348,0.00081821607],"genre_scores_gemma":[0.9889282,0.0038822202,0.0012523335,0.0021488117,0.00041551556,0.0009076276,0.0013785244,0.0003430894,0.00074367557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960198,0.00022397809,0.0007480126,0.0012147714,0.00085389323,0.00093958393],"domain_scores_gemma":[0.9970629,0.00043326896,0.00035889517,0.0015332578,0.00020416544,0.00040750156],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00018285487,0.0009254205,0.0010379312,0.00021259581,0.00023211275,0.000082877435,0.00049213914,0.00042634975,0.001945916],"category_scores_gemma":[0.00009639396,0.0007920283,0.00068183005,0.00033848285,0.0001527853,0.00011634797,0.000046997764,0.00035656733,0.00048546022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012417865,0.0014285566,0.00071490544,0.000054731616,0.000874618,0.00010253683,0.00019024735,0.000032802775,0.88741094,0.000016197597,0.007467912,0.100464754],"study_design_scores_gemma":[0.021217592,0.0019256566,0.00070112175,0.00018716074,0.00017432027,0.00000419229,0.000015193882,0.0018840285,0.90735835,0.00007911306,0.06578276,0.00067049527],"about_ca_topic_score_codex":0.0003329859,"about_ca_topic_score_gemma":0.00000391005,"teacher_disagreement_score":0.09979425,"about_ca_system_score_codex":0.0021175279,"about_ca_system_score_gemma":0.0002659683,"threshold_uncertainty_score":0.99945307},"labels":[],"label_agreement":null}]}